Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optilume drug-coated balloon for BPH
NCT03423979Phase 2Completed
- Sponsor
- Urotronic
- Start
- Dec 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of paclitaxel in benign prostatic hyperplasia (BPH), sponsored by Urotronic. Started Dec 2017; status: completed.
02
Drugs
paclitaxel
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT03423979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03423979.